Carisma Therapeutics share price logo

Carisma Therapeutics

OTC: CARM

$0.00

Live

as on

Carisma Therapeutics Stock Performance

as on October 24, 2026 at 12:30 am IST

  • Day's Low

    Day's High

    $0.01
    $0.02
    downward going graph

    -4900.00%

    Downside

    9900.00%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $0.00
    $0.10
    downward going graph

    50.00%

    Downside

    49900.00%

    Upside

    downward going graph

Carisma Therapeutics share price movements today

Previous Close
$0.00
Open
$0.01
Volume
24.0K
Market Cap
$20.9K
Day's Low - High
$0.01 - $0.02
52 Week Low - High
$0.00 - $0.10

Carisma Therapeutics Historical Returns

1 Month Return
-71.43 %
3 Month Return
-96.08 %
1 Year Return
-99.45 %
3 Year Return
-99.99 %
5 Year Return
0 %

Carisma Therapeutics Stock Fundamentals & Key Indicators

Check Carisma Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$20.9K

EPS (TTM)

0.2

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

Industry PE ratio

-3.98

PEG Ratio

0.00

EBITDA

13.7M

Revenue (TTM)

52.6M

Profit Margin

99.21%

Return On Equity TTM

-149.10%

Carisma Therapeutics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Carisma Therapeutics with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Buy$20.9KNANA99.21%0.00%
StrongBuy$30.1B14.44%36.9079.72%0.00%
StrongBuy$44.0BNA27.4787.82%0.00%
StrongBuy$132.9B191.61%30.2886.04%0.00%
Buy$83.1B43.11%19.2484.86%0.46%

Stock Returns calculator for Carisma Therapeutics Stock including INR - Dollar returns

The Carisma Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Carisma Therapeutics investment value today

Current value as on today

₹593

Returns

-₹99,407

(-99.41%)

Returns from Carisma Therapeutics Stock

-₹99,452 (-99.45%)

Dollar Impact

₹45 (+0.04%)

Analyst Recommendation on Carisma Therapeutics Stock

Based on 12 analysts

BUY

91.67%

Buy

8.33%

Hold

0.00%

Sell

Based on 12 analysts, 91.67% of analysts recommend a 'BUY' rating for Carisma Therapeutics. Average target price of $1

Carisma Therapeutics Share Price Target

Get share price movements and forecasts by analysts on Carisma Therapeutics.

What analysts predicted

99.98%UPSIDE

Target Price

$1

Current Price

$0.0002

Analyzed by

12 Analysts

Target

$1.00

Carisma Therapeutics target price $1, a slight upside of 99.98% compared to current price of $0.0002. According to 12 analysts rating.

Indian Investors' Interest in Carisma Therapeutics Stock

Search interest for Carisma Therapeutics Stock has increased by 2233% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:2233% versus previous 30 day period

Carisma Therapeutics Quarterly Profit & Loss

All numbers in Millions USD

Sep 2022
Mar 2023
Jun 2023
Sep 2023
Mar 2024
Jun 2024
Sep 2024
Mar 2025
Jun 2025
Sep 2025
Total Revenue
2
3
3
3
3
9
3
3
-
45
Gross Profit
-12
2
-14
-15
-14
-6
3
3
0
45
Operating Income
-16
-22
-20
-22
-19
-11
-13
-9
-5
43
EBITDA
-16
-22
-20
-21
-17
-11
-12
-8
-5
44
Interest Expense
0
1
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
1
0
0
0
0
-
Income Before Tax
-18
-24
-19
-21
-18
-11
-12
-9
-9
44
Income Tax Expense
-
0
0
-
-
-
-
-
-
-
Net Income
-18
-24
-19
-21
-18
-11
-12
-9
-9
44
Net Profit Margin
-503.45%
78.26%
-420.17%
-410.87%
-414.04%
-66.43%
100.00%
100.00%
0.00%
100.00%

Carisma Therapeutics Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Mar 2023
Mar 2024
Mar 2025
Total Revenue
0
-
-
11
26
9
14
19
Gross Profit
0
0
0
11
26
9
-59
-40
Operating Income
-19
-25
-36
-28
-28
-56
-88
-62
EBITDA
-28
-33
-107
-27
-7
-51
-85
-56
Interest Expense
-
-
-
-
-
3
-
-
Depreciation
0
0
0
0
0
6
2
3
Income Before Tax
-29
-33
-107
-28
-8
-61
-86
-60
Income Tax Expense
-
0
-
-
-8
-
-
-
Net Income
-29
-33
-107
-28
0
-61
-86
-60
Net Profit Margin
100.00%
0.00%
0.00%
100.00%
99.68%
100.00%
-396.85%
-203.96%

Carisma Therapeutics Quarterly Cash Flow

All numbers in Millions USD

Sep 2022
Mar 2023
Jun 2023
Sep 2023
Mar 2024
Jun 2024
Sep 2024
Mar 2025
Jun 2025
Sep 2025
Net Income
-18
-24
-19
-21
-18
-11
-12
-9
-9
44
Operating Cash Flow
-8
-25
-18
-20
-22
-16
-13
-10
-5
1
Investing Cash Flow
-2
-3
35
29
0
0
-
0
0
-
Financing Cash Flow
0
67
-3
-2
1
0
0
0
-
-1
Change in Cash
0
38
13
6
-21
-16
-13
-10
-5
0

Carisma Therapeutics Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Mar 2023
Mar 2024
Mar 2025
Net Income
-29
-33
-107
-28
-40
-61
-86
-60
Operating Cash Flow
-17
-22
-37
-27
-37
-7
-81
-59
Investing Cash Flow
0
0
0
0
-1
-32
72
0
Financing Cash Flow
7
58
35
72
15
35
62
0
Change in Cash
-10
35
-2
44
-23
-138
53
-59

Global Institutional Holdings in Carisma Therapeutics

Check out the Institutions with significant holdings in Carisma Therapeutics.

Funds
Holdings
TIAA-CREF Funds
0.20%
Fidelity Commonwealth Trust II
0.04%
Northern Funds
0.02%
Victory Portfolios III
0.00%

Insights on Carisma Therapeutics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 3 quarters, 3.38M → 3.72M (in $), with an average increase of 4.7% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 61.8% return, outperforming this stock by 157.0%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, CARM stock has moved down by -83.1%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, -9.26M → -9.77M (in $), with an average decrease of 5.5% per quarter

About Carisma Therapeutics

Carisma Therapeutics, Inc., a biotechnology company, focuses on developing transformative therapies to treat liver fibrosis and cancer in the United States. Its product candidates include CT-2401, which is in preclinical trial for the treatment of liver fibrosis. The company also develops CT-1119, a mesothelin-targeted CAR-Monocyte that is in phase I clinical trial to treat patients with advanced mesothelin-positive solid tumors, including pancreatic cancer, ovarian cancer, lung cancer, mesothelioma, and others. In addition, it develops in vivo CAR-M cell therapy to treat solid tumors, including hepatocellular carcinoma. Carisma Therapeutics, Inc. has collaboration and license agreement with ModernaTX, Inc. to address oncology gene therapies. The company was formerly known as CARMA Therapeutics Inc. and changed its name to Carisma Therapeutics, Inc. in May 2017. Carisma Therapeutics, Inc. was founded in 2016 and is headquartered in Philadelphia, Pennsylvania.
OrganisationCarisma Therapeutics
Headquarters3675 Market Street, Philadelphia, PA, 19104, US
IndustryBiotechnology
CEOCraig R. Jalbert

Key Management of Carisma Therapeutics

Name

Title

Dr. Saar Gill M.D., Ph.D.

Co-Founder & Chairman of Scientific Advisory Board

Ms. Natalie McAndrew

Vice President of Finance

FAQs

What is Carisma Therapeutics share price today?

Carisma Therapeutics share price today is $0.00 as on . Carisma Therapeutics share today touched a day high of $0.02 and a low of $0.01.

What is the 52 week high and 52 week low for Carisma Therapeutics share?

Carisma Therapeutics share touched a 52 week high of $0.10 on and a 52 week low of $0.00 on . Carisma Therapeutics stock price today i.e. is trending at $0.00,which is 99.80% down from its 52 week high and 100.00% up from its 52 week low.

What is Carisma Therapeutics's market capitalisation today?

Carisma Therapeutics market capitalisation is $0.00T as on .

How to invest in Carisma Therapeutics Stock (CARM) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Carisma Therapeutics on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Carisma Therapeutics Stock (CARM) from India?

Indian investors can start investing in Carisma Therapeutics (CARM) shares with as little as ₹94.94000244140625 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.40 in Carisma Therapeutics stock (as per the Rupee-Dollar exchange rate as on ). Based on Carisma Therapeutics share’s latest price of $0.00 as on October 23, 2026 at 7:00 pm IST, you will get 50000.0000 shares of Carisma Therapeutics. Learn more about fractional shares .